Literature DB >> 222688

Persistent infection of a human lymphoblastoid cell line with equine herpesvirus 1.

L F Roumillat, P M Feorino, P D Lukert.   

Abstract

Infection of a human lymphoblastoid cell line (Jijoye line derived from a Burkitt lymphoma which contains Epstein-Barr virus) with equine herpesvirus 1, maintained and observed for 53 days, was characterized by the continuous production of infectious extracellular and intracellular virus. Maximum virus production correlated with active cell multiplication. Less than 15% of the cells possessed viral capsid antigen at any one time. Five percent of the cells in the Jijoye line possess Epstein-Barr viral capsid antigen; 80% of the Epstein-Barr viral caspid-containing cells also contained equine herpesvirus 1 antigen as detected by double staining. The interaction of equine herpesvirus 1 and lymphoblastoid cells provides a useful in vitro model which may help clarify the mechanism for herpesvirus latency.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222688      PMCID: PMC414333          DOI: 10.1128/iai.24.2.539-544.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  CYTOLOGY OF BURKITT'S TUMOUR (AFRICAN LYMPHOMA).

Authors:  J V PULVERTAFT
Journal:  Lancet       Date:  1964-02-01       Impact factor: 79.321

2.  A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE.

Authors:  J V PULVERTAFT
Journal:  J Clin Pathol       Date:  1965-05       Impact factor: 3.411

3.  Evaluation of two types of infectious mononucleosis antigen slides by the indirect fluorescent-antibody technique.

Authors:  L A Dye; P M Feorino
Journal:  Appl Microbiol       Date:  1973-02

4.  Studies on the growth of herpes simplex virus in lymphoblastoid cells.

Authors:  R Floyd; R Glasser; V Vonka; M Benyesh-Melnick
Journal:  Acta Virol       Date:  1971-03       Impact factor: 1.162

5.  On immunity to disease caused by equine herpesvirus 1.

Authors:  J T Bryans
Journal:  J Am Vet Med Assoc       Date:  1969-07-15       Impact factor: 1.936

6.  Effect of herpes simplex virus on cultured Burkitt tumor cells and its failure to influence the Epstein-Barr virus carrier state.

Authors:  W Henle; G Henle; H zur Hausen
Journal:  Cancer Res       Date:  1969-02       Impact factor: 12.701

7.  Autogenous and virus-induced interferons from lines of lymphoblastoid cells.

Authors:  B A Zajac; W Henle; G Henle
Journal:  Cancer Res       Date:  1969-08       Impact factor: 12.701

8.  Epstein-Barr virus antigens, marker chromosome, and interferon production in clones derived from cultured Burkitt tumor cells.

Authors:  B A Zajac; G Kohn
Journal:  J Natl Cancer Inst       Date:  1970-08       Impact factor: 13.506

9.  Direct implantation and serial transplantation of human acute lymphoblastic leukemia in hamsters, SB-2.

Authors:  R A Adams; A Flowers; B J Davis
Journal:  Cancer Res       Date:  1968-06       Impact factor: 12.701

10.  MORPHOLOGICAL AND BIOLOGICAL STUDIES ON A VIRUS IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors:  M A EPSTEIN; G HENLE; B G ACHONG; Y M BARR
Journal:  J Exp Med       Date:  1965-05-01       Impact factor: 14.307

View more
  4 in total

1.  Analysis and characterization of herpes simplex virus after its persistence in a lymphoblastoid cell line for 15 months.

Authors:  L F Roumillat; P M Feorino; D D Caplan; P D Lukert
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

2.  Persistent infection with mouse hepatitis virus 3 in mouse lymphoid cell lines.

Authors:  L M Lamontagne; J M Dupuy
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

Review 3.  Evaluation of the human host range of bovine and porcine viruses that may contaminate bovine serum and porcine trypsin used in the manufacture of biological products.

Authors:  Carol Marcus-Sekura; James C Richardson; Rebecca K Harston; Nandini Sane; Rebecca L Sheets
Journal:  Biologicals       Date:  2011-10-13       Impact factor: 1.856

Review 4.  Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production.

Authors:  Felipe Tapia; Daniel Vázquez-Ramírez; Yvonne Genzel; Udo Reichl
Journal:  Appl Microbiol Biotechnol       Date:  2016-01-13       Impact factor: 4.813

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.